4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-13-015174
Director sold 10,000 shares at $5.70 ($57,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Akirov Alfred Director | 2013-03-12 | Sale | −10,000 | $5.70 | $57,000 | 5,027,713 | I |
| Open-market sales · 10,000 sh · avg $5.70 · $57,000 | |||||||
Loading xslF345X03/v338224_4.xml…